JP2012511028A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012511028A5 JP2012511028A5 JP2011539772A JP2011539772A JP2012511028A5 JP 2012511028 A5 JP2012511028 A5 JP 2012511028A5 JP 2011539772 A JP2011539772 A JP 2011539772A JP 2011539772 A JP2011539772 A JP 2011539772A JP 2012511028 A5 JP2012511028 A5 JP 2012511028A5
- Authority
- JP
- Japan
- Prior art keywords
- compound according
- compound
- pharmaceutical composition
- diabetes
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- CGAMDQCXAAOFSR-UHFFFAOYSA-N CCCCCN(c1c(C(N2)=O)[nH]c(Cl)n1)C2=O Chemical compound CCCCCN(c1c(C(N2)=O)[nH]c(Cl)n1)C2=O CGAMDQCXAAOFSR-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12059608P | 2008-12-08 | 2008-12-08 | |
| US61/120,596 | 2008-12-08 | ||
| PCT/US2009/066941 WO2010068581A1 (en) | 2008-12-08 | 2009-12-07 | Novel compounds |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012511028A JP2012511028A (ja) | 2012-05-17 |
| JP2012511028A5 true JP2012511028A5 (enExample) | 2013-01-31 |
| JP5666464B2 JP5666464B2 (ja) | 2015-02-12 |
Family
ID=42243044
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011539772A Expired - Fee Related JP5666464B2 (ja) | 2008-12-08 | 2009-12-07 | 新規化合物 |
Country Status (22)
| Country | Link |
|---|---|
| US (3) | US9163024B2 (enExample) |
| EP (1) | EP2370440B1 (enExample) |
| JP (1) | JP5666464B2 (enExample) |
| KR (1) | KR101743783B1 (enExample) |
| CN (1) | CN102245606B (enExample) |
| AU (1) | AU2009324811B2 (enExample) |
| BR (1) | BRPI0922134A2 (enExample) |
| CA (1) | CA2746316C (enExample) |
| CY (1) | CY1116032T1 (enExample) |
| DK (1) | DK2370440T3 (enExample) |
| EA (1) | EA020037B1 (enExample) |
| ES (1) | ES2527354T3 (enExample) |
| HR (1) | HRP20150026T1 (enExample) |
| IL (1) | IL213032A (enExample) |
| MX (1) | MX2011006022A (enExample) |
| PL (1) | PL2370440T3 (enExample) |
| PT (1) | PT2370440E (enExample) |
| RS (1) | RS53777B1 (enExample) |
| SI (1) | SI2370440T1 (enExample) |
| SM (1) | SMT201500012B (enExample) |
| WO (1) | WO2010068581A1 (enExample) |
| ZA (1) | ZA201103397B (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101103030B (zh) * | 2004-02-14 | 2010-10-13 | 史密丝克莱恩比彻姆公司 | 具有hm74a受体活性的药物 |
| JP2009504592A (ja) | 2005-08-10 | 2009-02-05 | スミスクライン・ビーチャム・コーポレイション | 選択的ｈｍ７４ａアゴニストとしてのキサンチン誘導体 |
| ES2674951T3 (es) * | 2012-03-22 | 2018-07-05 | Transtech Pharma, Llc | Sales de tris(hidroximetil)aminometano de un agonista de GLP1R de molécula pequeña y composiciones farmacéuticas y usos de las mismas |
| AU2024229006A1 (en) * | 2023-02-27 | 2025-09-18 | Shanton Pharma Pte. Ltd. | Crystal form of 8-chloro-3-pentyl-3,7-dihydro-1h-purin-2,6-dione compound and preparation method therefor |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3657327A (en) * | 1970-06-01 | 1972-04-18 | Upjohn Co | Prostaglandin salts of tris(hydroxymethyl)aminomethane |
| US4647585A (en) * | 1984-11-08 | 1987-03-03 | E. R. Squibb & Sons, Inc. | Bicycloheptane substituted ethers |
| WO2001043692A2 (en) * | 1999-12-15 | 2001-06-21 | Smithkline Beecham Corporation | SALTS OF Cis-4-CYANO-4-[3-(CYCLOPENTYLOXY)-4-METHOXYPHENYL]CYCLOHEXANE-1-CARBOXYLIC ACID |
| US20030013905A1 (en) | 2002-06-10 | 2003-01-16 | Huang Guishu Kris | Salts of cis-4-cyano-4[3(cyclopentyloxy)-4-methoxyphenyl]cyclohexane-1-carboxylic acid |
| CN101103030B (zh) * | 2004-02-14 | 2010-10-13 | 史密丝克莱恩比彻姆公司 | 具有hm74a受体活性的药物 |
| GB0423568D0 (en) * | 2004-10-22 | 2004-11-24 | Smithkline Beecham Corp | Novel compounds |
| US20090209561A1 (en) | 2004-10-22 | 2009-08-20 | Richard Jonathan Daniel Hatley | Xanthine Derivatives with HM74A Receptor Activity |
| JP2009504592A (ja) | 2005-08-10 | 2009-02-05 | スミスクライン・ビーチャム・コーポレイション | 選択的ｈｍ７４ａアゴニストとしてのキサンチン誘導体 |
| GB0516464D0 (en) * | 2005-08-10 | 2005-09-14 | Smithkline Beecham Corp | Novel compounds |
-
2009
- 2009-12-07 AU AU2009324811A patent/AU2009324811B2/en not_active Ceased
- 2009-12-07 BR BRPI0922134-4A patent/BRPI0922134A2/pt not_active Application Discontinuation
- 2009-12-07 US US13/133,486 patent/US9163024B2/en not_active Expired - Fee Related
- 2009-12-07 EA EA201170783A patent/EA020037B1/ru not_active IP Right Cessation
- 2009-12-07 PT PT98324213T patent/PT2370440E/pt unknown
- 2009-12-07 CA CA2746316A patent/CA2746316C/en not_active Expired - Fee Related
- 2009-12-07 KR KR1020117012975A patent/KR101743783B1/ko not_active Expired - Fee Related
- 2009-12-07 SI SI200931113T patent/SI2370440T1/sl unknown
- 2009-12-07 WO PCT/US2009/066941 patent/WO2010068581A1/en not_active Ceased
- 2009-12-07 RS RS20150086A patent/RS53777B1/sr unknown
- 2009-12-07 CN CN200980148973.7A patent/CN102245606B/zh not_active Expired - Fee Related
- 2009-12-07 MX MX2011006022A patent/MX2011006022A/es active IP Right Grant
- 2009-12-07 PL PL09832421T patent/PL2370440T3/pl unknown
- 2009-12-07 DK DK09832421.3T patent/DK2370440T3/en active
- 2009-12-07 JP JP2011539772A patent/JP5666464B2/ja not_active Expired - Fee Related
- 2009-12-07 ES ES09832421.3T patent/ES2527354T3/es active Active
- 2009-12-07 HR HRP20150026AT patent/HRP20150026T1/hr unknown
- 2009-12-07 EP EP09832421.3A patent/EP2370440B1/en active Active
-
2011
- 2011-05-10 ZA ZA2011/03397A patent/ZA201103397B/en unknown
- 2011-05-19 IL IL213032A patent/IL213032A/en not_active IP Right Cessation
-
2014
- 2014-12-16 CY CY20141101047T patent/CY1116032T1/el unknown
-
2015
- 2015-01-16 SM SM201500012T patent/SMT201500012B/xx unknown
- 2015-08-31 US US14/840,549 patent/US20150366870A1/en not_active Abandoned
-
2016
- 2016-10-11 US US15/289,996 patent/US20170027945A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI4157832T3 (fi) | Glp-1r-agonistien suola- ja kidemuotoja ja niiden käyttötarkoituksia | |
| JP2007522176A5 (enExample) | ||
| JP2012511028A5 (enExample) | ||
| JP2011528362A5 (enExample) | ||
| JP2016041701A5 (enExample) | ||
| NO343371B1 (no) | Nye forbindelser med DGAT1-aktivitet, farmasøytiske sammensetninger inneholdende slike og anvendelse derav | |
| WO2006067224A3 (en) | Spiro-benzodioxole and spiro-benzodioxane compounds as orexin receptor antagonists | |
| WO2004111031A1 (en) | Pyridinyl carbamates as hormone-sensitive lipase inhibitors | |
| JP2008521831A5 (enExample) | ||
| JP2007502264A5 (enExample) | ||
| WO2009056070A1 (en) | Ligustrazine aromatic acid ether derivative, its preparation method, pharmaceutical composition, and application | |
| CN1057051A (zh) | 羟基和烷氧基吡啶衍生物 | |
| JP2013506670A5 (enExample) | ||
| JP2017521457A5 (enExample) | ||
| JP2011508775A5 (enExample) | ||
| RU2015144182A (ru) | Пиразоламидное соединение и его применения в медицине | |
| JP2016500063A5 (enExample) | ||
| WO2014025942A1 (en) | Nmda receptor modulators and uses related thereto | |
| JP2016513730A5 (enExample) | ||
| EP2308562A3 (en) | Azetidine ring compounds and drugs comprising the same | |
| WO2005123718A3 (en) | Benzimidazolone carboxylic acid derivatives | |
| HRP20150026T1 (hr) | 8-klor-3-pentil-3,7-dihidro-1h-purin-2,6-dion 2-amino-2-(hidroksimetil)-1,3-propandiol anhidrat za lijeäśenje bolesti | |
| RU2012113924A (ru) | 5-(3,4-дихлорфенил)-n-(2-гидроксициклогексил)-6-(2,2,2-трифторэтокси)никотинамид и его соли в качестве средств, повышающих концентрацию лвп холестерина | |
| EP3454852A1 (en) | Phosphotidylinositol 3-kinase inhibitors | |
| NZ601113A (en) | Carboxylic acid derivatives having a 2,5-substituted oxazolopyrimidine ring |